Home › Merck KGaA brain tumor drug fails clinical trial
 

Keywords :   


Merck KGaA brain tumor drug fails clinical trial

2013-02-25 15:33:17| Biotech - Topix.net

Merck KGaA's Cilengitide, an experimental drug to treat an aggressive type of brain tumor, has failed a large-scale clinical trial, dealing a blow to the German drugmaker's efforts to replenish its pipeline of medicines.

Tags: trial drug clinical brain

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »